Angiotensin?converting enzyme inhibitors and angiotensin?receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial

JohnA.Cairns

首页> 外文期刊>Polish Archives of Internal Medicine >Angiotensin?converting enzyme inhibitors and angiotensin?receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial

【24h】

Angiotensin?converting enzyme inhibitors and angiotensin?receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial

机译：预防性心脏病学中的血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂：使用哪种药物以及根据ONTARGET试验期望使用什么药物

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Polish Archives of Internal Medicine》 |2008年第6期|共4页
作者
JohnA.Cairns;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials. [J] . Lakhdar R, Al-Mallah MH, Lanfear DE Journal of cardiac failure . 2008,第3期

机译：血管紧张素转换酶抑制剂与血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂联合使用在左心功能不全患者中的安全性和耐受性：一项随机对照试验的系统评价和荟萃分析。
2. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials. [J] . Lakhdar R, Al-Mallah MH, Lanfear DE Journal of cardiac failure . 2008,第3期

机译：血管紧张素转换酶抑制剂与血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂联合使用在左心功能不全患者中的安全性和耐受性：一项随机对照试验的系统评价和荟萃分析。
3. Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor. [J] . Sleight P Journal of hypertension . 2009,第Suppla5期

机译：ONTARGET的临床证据：血管紧张素II受体阻滞剂和血管紧张素转化酶抑制剂的价值。
4. Angiotensin-converting enzyme inhibitor trials - much ado about nothing? [C] . Mark Rishniw, Richard D Kienle Annual Veterinary Medical Forum . 2000

机译：血管紧张素转换酶抑制剂试验 - 大约是什么？
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies [O] . Gábor Kriszta, Zsófia Kriszta, Szilárd Váncsa, 2021

机译：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对血管紧张素转化酶2水平的影响：基于动物研究的综合分析
7. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies [O] . Gábor Kriszta, Zsófia Kriszta, Szilárd Váncsa, 2021

机译：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对血管紧张素转化酶2水平的影响：基于动物研究的综合分析

Angiotensin?converting enzyme inhibitors and angiotensin?receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial

著录项

相似文献

相关主题

期刊订阅